In the Swedish BioFinder2 study, for example, MBI-C measured impulse dyscontrol was associated with both CSF tau and tau-PET (in Braak Stage I–II regions) in cognitively normal Aβ+ individuals (i.e., preclinical AD). The gene discussed is MAPT; the disease is Alzheimer disease.